Important note for investors: The operating business of Cannovum AG is located in Cannovum Health eG and is not included in the pure AG figures.
Facts and figures
+
1231
%
in sales compared to fiscal 2021
10
%
of all cannabis distributing pharmacies are our regular customers
OUR VISION
In 2023, a billion market for legal cannabis will emerge in Germany. Today, Cannovum AG is already in a pole position as one of the market leaders in the medicinal cannabis segment.
A commitment to the highest product quality and the satisfaction of our customers are our top priority.
Become part of the cannabis revolution and accompany us on our way as an investor, customer or partner.
>
8
Bn. €
Market potential for recreational cannabis in Germany per year*
June 2023 Release of annual financial statements Dec. 31, 2022
July 2023 Annual general meeting
September 2023 Release of half-year-financial-statements June 30, 2023
November 2022
Deutsches Eigenkapitalforum
Keine Daten verfügbar
Contact us
Erfolgreich abgesendet
Etwas ist beim absenden schief gegangen.
Klaus Madzia, CMO
Sign-Up for the investor newsletter
We keep you informed about all Cannovum news relevant to the stock.
Erfolgreich angemeldet
Etwas ist schief gegangen.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
